These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29120925)

  • 1. Noonan syndrome: an update on growth and development.
    Yart A; Edouard T
    Curr Opin Endocrinol Diabetes Obes; 2018 Feb; 25(1):67-73. PubMed ID: 29120925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Noonan syndrome: genetic and clinical update and treatment options].
    Carcavilla A; Suárez-Ortega L; Rodríguez Sánchez A; Gonzalez-Casado I; Ramón-Krauel M; Labarta JI; Quinteiro Gonzalez S; Riaño Galán I; Ezquieta Zubicaray B; López-Siguero JP
    An Pediatr (Engl Ed); 2020 Jul; 93(1):61.e1-61.e14. PubMed ID: 32493603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical manifestations of mutations in RAS and related intracellular signal transduction factors.
    Zenker M
    Curr Opin Pediatr; 2011 Aug; 23(4):443-51. PubMed ID: 21750428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the genetic spectrum of Noonan syndrome.
    Noordam K
    Horm Res; 2007; 68 Suppl 5():24-7. PubMed ID: 18174700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
    Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short stature and its treatment in Turner and Noonan syndromes.
    Chacko EM; Rapaport R
    Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):40-6. PubMed ID: 22157403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noonan syndrome, the Ras-MAPK signalling pathway and short stature.
    Binder G
    Horm Res; 2009 Apr; 71 Suppl 2():64-70. PubMed ID: 19407499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.
    Yamamoto GL; Aguena M; Gos M; Hung C; Pilch J; Fahiminiya S; Abramowicz A; Cristian I; Buscarilli M; Naslavsky MS; Malaquias AC; Zatz M; Bodamer O; Majewski J; Jorge AA; Pereira AC; Kim CA; Passos-Bueno MR; Bertola DR
    J Med Genet; 2015 Jun; 52(6):413-21. PubMed ID: 25795793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and pathogenetic aspects of Noonan syndrome and related disorders.
    Zenker M
    Horm Res; 2009 Dec; 72 Suppl 2():57-63. PubMed ID: 20029240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noonan syndrome.
    Roberts AE; Allanson JE; Tartaglia M; Gelb BD
    Lancet; 2013 Jan; 381(9863):333-42. PubMed ID: 23312968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on Turner and Noonan syndromes.
    Chacko E; Graber E; Regelmann MO; Wallach E; Costin G; Rapaport R
    Endocrinol Metab Clin North Am; 2012 Dec; 41(4):713-34. PubMed ID: 23099266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noonan syndrome associated with hypoplastic left heart syndrome.
    Lawrence KM; Burstein DS; Ahrens-Nicklas R; Gaynor JW; Nuri MA
    Cardiol Young; 2023 Apr; 33(4):652-654. PubMed ID: 35989466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived motor problems in daily life: Focus group interviews with people with Noonan syndrome and their relatives.
    Croonen EA; Harmsen M; Van der Burgt I; Draaisma JM; Noordam K; Essink M; Nijhuis-van der Sanden MW
    Am J Med Genet A; 2016 Sep; 170(9):2349-56. PubMed ID: 27338165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noonan syndrome: clinical features, diagnosis, and management guidelines.
    Romano AA; Allanson JE; Dahlgren J; Gelb BD; Hall B; Pierpont ME; Roberts AE; Robinson W; Takemoto CM; Noonan JA
    Pediatrics; 2010 Oct; 126(4):746-59. PubMed ID: 20876176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supporting children with Noonan syndrome.
    Lloyd S
    Paediatr Nurs; 2007 Nov; 19(9):41. PubMed ID: 18047172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies.
    Komatsuzaki S; Aoki Y; Niihori T; Okamoto N; Hennekam RC; Hopman S; Ohashi H; Mizuno S; Watanabe Y; Kamasaki H; Kondo I; Moriyama N; Kurosawa K; Kawame H; Okuyama R; Imaizumi M; Rikiishi T; Tsuchiya S; Kure S; Matsubara Y
    J Hum Genet; 2010 Dec; 55(12):801-9. PubMed ID: 20882035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Noonan syndrome can be diagnosed clinically and through molecular genetic analyses].
    Henningsen MK; Jelsig AM; Andersen H; Brusgaard K; Ousager LB; Hertz JM
    Ugeskr Laeger; 2015 Aug; 177(32):V12140755. PubMed ID: 26321587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancy in Noonan syndrome and related disorders.
    Smpokou P; Zand DJ; Rosenbaum KN; Summar ML
    Clin Genet; 2015 Dec; 88(6):516-22. PubMed ID: 25683281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical symptoms and molecular pathogenesis of Noonan syndrome--current concepts].
    Klapecki J; Obersztyn E; Laniewski-Wollk M; Szpecht-Potocka A; Mazurczak T
    Med Wieku Rozwoj; 2006; 10(1 Pt 2):289-308. PubMed ID: 17028394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
    Binder G; Neuer K; Ranke MB; Wittekindt NE
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.